| Diphtheria Toxoid | 🇨🇦Canada | 50 LF / ML | Liquid | Cancelled | Aventis Pasteur Limited |
| Diphtheria Toxoid Immunization of Reactors | 🇨🇦Canada | 4 LF / ML | Liquid | Cancelled | Aventis Pasteur Limited |
| Diphtheria Toxoid for Reaction Test 0.2LF/ML | 🇨🇦Canada | 0.2 LF / ML | Liquid | Cancelled | Aventis Pasteur Limited |
| Diphtheria Toxoid for Schick Control 0.2LF/ML | 🇨🇦Canada | 0.2 LF / ML | Liquid | Cancelled | Connaught Laboratories LTD. |
| D2T5 Diphtheria and Tetanus Toxoid AdsorbedCombination | 🇨🇦Canada | 2 LF / 0.5 ML + 5 LF / 0.5 ML | Suspension | Cancelled | Iaf Biovac INC. |
| Tetanus and Diphtheria Toxoids Adsorbed for Adult UseCombination | 🇨🇦Canada | 2 LF / 0.5 ML + 5 LF / 0.5 ML | Suspension | Cancelled | Lederle Labs, Division of American Cyanamid Co |
| Diphtheria and Tetanus Toxoids and Pertussis Vaccine AdsorbedCombination | 🇹🇼Taiwan | | 注射劑 | Cancelled | 法台化學股份有限公司 |
| Diphtheria and Tetanus Toxoids with Pertussis Vaccine AdsorbedCombination | 🇨🇦Canada | 25 LF / 0.5 ML + 12 UNIT / 0.5 ML + 5 LF / 0.5 ML | Liquid | Cancelled | Aventis Pasteur Limited |
| AdacelCombination | 🇨🇦Canada | 2 LF / 0.5 ML + 5 MCG / 0.5 ML + 5 MCG / 0.5 ML + 3 MCG / 0.5 ML + 2.5 MCG / 0.5 ML + 5 LF / 0.5 ML | Suspension | Marketed | Sanofi Vaccines Canada LTD. |
| Adacel-PolioCombination | 🇨🇦Canada | 2 LF / 0.5 ML + 5 MCG / 0.5 ML + 5 MCG / 0.5 ML + 3 MCG / 0.5 ML + 2.5 MCG / 0.5 ML + 29 UNIT / 0.5 ML + 7 UNIT / 0.5 ML + 26 UNIT / 0.5 ML + 5 LF / 0.5 ML | Suspension | Marketed | Sanofi Vaccines Canada LTD. |
| BoostrixCombination | 🇨🇦Canada | 2 UNIT / 0.5 ML + 8 MCG / 0.5 ML + 2.5 MCG / 0.5 ML + 8 MCG / 0.5 ML + 20 UNIT / 0.5 ML | Suspension | Marketed | Glaxosmithkline INC |
| Infanrix HexaCombination | 🇨🇦Canada | 25 LF / 0.5 ML + 25 MCG / 0.5 ML + 10 MCG / 0.5 ML + 10 MCG / 0.5 ML + 8 MCG / 0.5 ML + 25 MCG / 0.5 ML + 40 UNIT / 0.5 ML + 8 UNIT / 0.5 ML + 32 UNIT / 0.5 ML + 10 LF / 0.5 ML + 40 MCG / 0.5 ML | Suspension | Marketed | Glaxosmithkline INC |
| Infanrix-Ipv/HibCombination | 🇨🇦Canada | 30 UNIT / 0.5 ML + 25 MCG / 0.5 ML + 10 MCG / 0.5 ML + 40 UNIT / 0.5 ML + 8 UNIT / 0.5 ML + 32 UNIT / 0.5 ML + 8 MCG / 0.5 ML + 25 MCG / 0.5 ML + 40 UNIT / 0.5 ML | Suspension | Marketed | Glaxosmithkline INC |
| PentacelCombination | 🇨🇦Canada | 15 LF / 0.5 ML + 20 MCG / 0.5 ML + 5 MCG / 0.5 ML + 10 MCG / 0.5 ML + 3 MCG / 0.5 ML + 20 MCG / 0.5 ML + 29 UNIT / 0.5 ML + 7 UNIT / 0.5 ML + 26 UNIT / 0.5 ML + 30 MCG / 0.5 ML + 5 LF / 0.5 ML | Suspension | Marketed | Sanofi Vaccines Canada LTD. |
| QuadracelCombination | 🇨🇦Canada | 15 LF / 0.5 ML + 20 MCG / 0.5 ML + 5 MCG / 0.5 ML + 3 MCG / 0.5 ML + 20 MCG / 0.5 ML + 29 UNIT / 0.5 ML + 7 UNIT / 0.5 ML + 26 UNIT / 0.5 ML + 5 LF / 0.5 ML | Suspension | Marketed | Sanofi Vaccines Canada LTD. |
| TripacelCombination | 🇨🇦Canada | 15 LF / 0.5 ML + 5 MCG / 0.5 ML + 5 MCG / 0.5 ML + 3 MCG / 0.5 ML + 10 MCG / 0.5 ML + 5 LF / 0.5 ML | Suspension | Authorised | Sanofi Vaccines Canada LTD. |
| Boostagen Suspension for InjectionCombination | 🇸🇬Singapore | 2.0 Lf/0.5 ml + 5 ug/0.5 ml + 5 ug/0.5 ml + 7.5 Lf/0.5 ml | injection, suspension | Authorised | Novem Healthcare Pte LTD |
| Boostrix Polio Suspension for InjectionCombination | 🇸🇬Singapore | 2.5 Lf/ 0.5 ml - not less than 2 IU + 8 mcg/0.5ml + 40 DU/0.5 ml + 8 DU/0.5 ml + 32 DU/0.5 ml + 2.5 mcg/0.5 ml + 8 mcg/0.5 ml + 5.0 Lf/0.5ml - not less than 20 IU | injection, suspension | Authorised | Glaxosmithkline Pte LTD |
| Boostrix VaccineCombination | 🇸🇬Singapore | 2 iu/0.5 ml + 8 mcg/0.5 ml + 2.5 mcg/0.5 ml + 8 mcg/0.5 ml + 20 iu/0.5 ml | injection | Authorised | Glaxosmithkline Pte LTD |
| Hexaxim Suspension for Injection in Pre-Filled SyringeCombination | 🇸🇬Singapore | 30 Lf (>= 20 IU)/0.5 mL + 25 μg/0.5 mL + 12 μg/0.5 mL + 10 μg/0.5 mL + 25 μg/0.5 mL + 29 DU/0.5 mL + 7 DU/0.5 mL + 26 DU/0.5 mL + 10 Lf (>= 40 IU)/0.5 mL | injection, suspension | Authorised | Sanofi-Aventis Singapore Pte. LTD. |
| Infanrix Hexa VaccineCombination | 🇸🇬Singapore | min 30 iu/0.5 ml + 25 mcg/0.5 ml + 10 mcg/0.5 ml + 10 mcg/0.5 ml + 8 mcg/0.5 ml + 25 mcg/0.5 ml + 40 du/0.5 ml + 8 du/0.5 ml + 32 du/0.5 ml + min 40 iu/0.5 ml | injection | Authorised | Glaxosmithkline Pte LTD |
| Infanrix Ipv+Hib VaccineCombination | 🇸🇬Singapore | min 30IU/0.5ml + 25mcg/0.5ml + 10 mcg/0.5 ml + 8mcg/0.5ml + 25mcg/0.5ml + 40DU/0.5ml + 8DU/0.5ml + 32DU/0.5ml + min 40IU/0.5ml | injection | Authorised | Glaxosmithkline Pte LTD |
| Pentaxim VaccineCombination | 🇸🇬Singapore | min. 20 IU (30 Lf)/0.5 mL + 25 μg/0.5 mL + 25 μg/0.5 mL + 29 DU/0.5 mL + 7 DU/0.5 mL + 26 DU/0.5 mL + min. 40 IU (10 Lf) /0.5 mL + 10 μg/0.5 mL + 18 - 30 μg/0.5 mL | injection, powder, for suspension | Authorised | Sanofi-Aventis Singapore Pte. LTD. |
| TenivacCombination | 🇺🇸United States | 5LF,2LF/.5ML | Injection | Marketed | Sanofi Vaccines Canada Ltd. |
| TenivacCombination | 🇺🇸United States | 5LF,2LF/.5ML | Injection | Marketed | Sanofi Vaccines Canada Ltd. |
